Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
viernes, octubre 09
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Aethlon Medical Inc
AEMD
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$6.03
0.0194
0.32%
Últ. Act.: Oct 9, 7:51 AM
$6.03
0.0194
0.32%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Privacy Manager
Aethlon Medical Financials
Aethlon Medical (AEMD) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall
U.S. stocks climbed Thursday, led by Nasdaq’s 1.54% gain, as jobless claims fell to 196,000. AEMD surged 401%, while RETO plunged 84%.
Avi Kapoor
PRO
Aethlon Medical Q1 EPS $(4.02) Misses $(0.79) Estimate; Cash & Equivalents $4.9M
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(4.02) per share which missed the analyst consensus estimate of $(0.79) by 415.38 percent. This is a 90.52 percent increase over losses of $(42.42) per share
Benzinga Newsdesk
PRO
Aethlon Medical Q4 EPS $0.40 Beats $(2.02) Estimate
Aethlon Medical (NASDAQ:AEMD) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $(2.02) by 119.9 percent. This is a 110.81 percent increase over losses of $(3.70) per share from
Benzinga Newsdesk
Earnings Scheduled For June 10, 2026
Benzinga Insights
PRO
Aethlon Medical Q3 EPS $(2.45) Beats $(2.57) Estimate
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(2.45) per share which beat the analyst consensus estimate of $(2.57) by 4.67 percent. This is a 135.58 percent decrease over losses of $(1.04) per share from
Benzinga Newsdesk
Earnings Scheduled For February 12, 2026
Benzinga Insights
